Ibu-Lysin Al

Ibuprofen, the active ingredient in Ibu-Lysin Al, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is employed to relieve mild to moderate pain, reduce fever, and manage inflammatory conditions such as osteoarthritis and rheumatoid arthritis in adult patients across the European market.

GNH USA supplies Ibu-Lysin Al as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and offering reliable global distribution.

Ibu-Lysin Al, an NSAID, acts on prostaglandin-mediated pathways to alleviate symptoms of several common conditions. - Pain: provides relief of mild to moderate acute pain. - Fever: reduces elevated body temperature. - Osteoarthritis: eases joint pain and inflammation. - Rheumatoid arthritis: helps control inflammatory symptoms. - Dental pain: alleviates discomfort associated with dental procedures.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin irritation or erythema. - Elevated liver enzymes: occasional mild increase in hepatic markers. - Fluid retention: mild peripheral edema.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Severe renal impairment or acute kidney injury. - Anaphylaxis or severe allergic reactions. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity with marked liver enzyme elevation. - Cardiovascular events such as myocardial infarction in high‑risk patients.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in patients with existing kidney disease. - Review gastrointestinal history: avoid in active ulcer disease or recent GI bleeding. - Evaluate bleeding risk: use cautiously with anticoagulants or antiplatelet agents. - Monitor asthma status: ibuprofen may precipitate bronchospasm in susceptible individuals. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Ibuprofen may interact with several drug classes, requiring careful management. Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: potential elevation of lithium serum concentrations. Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in volume‑depleted patients. - Diuretics: heightened risk of renal impairment. - Methotrexate: possible increase in methotrexate toxicity. - SSRIs or SNRIs: may modestly raise bleeding tendency. - Corticosteroids: combined use can exacerbate gastrointestinal ulcer risk.